They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...

Dr. Emmanuel Walter, chief medical office of the Duke Human Vaccine Institute and professor of pediatrics at Duke University ...

Prominent cardiologist Dr. Peter McCullough on Thursday called on president-elect Donald Trump to pull the COVID-19 vaccine ...

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory syncytial virus vaccine raked in just $10 ...

With the possibility of Robert F. Kennedy, Jr. being involved in health policy in the next administration, vaccination – ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

For effective prevention, vaccines must stimulate mucosal immunity – an immune response in the respiratory tract where ...

The optimal time to get your seasonal flu shot, according to the Food and Drug Administration (FDA), is right now: flu ...

Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

Recent research suggests that protective antibodies from Covid-19 vaccines, specifically the mRNA type, tend to decline ...

Issuer: CureVac / Key word (s): Conference CureVac to Present at the 12th International mRNA Health Conference 04.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance, Ben Hargreaves finds the technology is poised to ...